Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chapman Innovations, primarily known through its flagship brand CarbonX, is a leader in the development of high-performance, flame-resistant (FR) fabrics and materials. While rooted in industrial safety and professional racing, the company's technologies have significant applications in healthcare, particularly in burn care and medical personal protective equipment (PPE). Their proprietary CarbonX technology utilizes a blend of oxidized polyacrylonitrile (OPAN) and other high-performance fibers to create materials that do not burn, melt, or ignite even when exposed to direct flame or extreme heat. The company was acquired by Gentex Corporation in 2012, integrating its advanced textile solutions into a broader portfolio of safety and protection products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chapman Innovations.